Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Adjunctive topical hemostatic agents combined with renorrhaphy versus renorrhaphy alone during partial nephrectomy: a systematic review and meta-analysis.
Journal: World journal of urology
Published: June 16, 2026
Role of Pelvic Lymph Node Dissection for Clinically Localized Prostate Cancer: Should It be Done?
Journal: The Urologic clinics of North America
Published: April 15, 2026
Saline-assisted Fascial Exposure Microultrasound-guided Nerve Preservation During Robotic Prostatectomy: Interim Analysis of a Randomized Controlled Trial.
Journal: European urology oncology
Published: March 22, 2026
NeuroSAFE-guided robot-assisted radical prostatectomy versus standard RARP: systematic review and meta-analysis of comparative studies.
Journal: Journal of robotic surgery
Published: March 01, 2026
Pembrolizumab Plus Platinum-Based Chemotherapy for Patients With Advanced Penile Cancer: The Nonrandomized HERCULES (LACOG 0218) Clinical Trial.
Journal: JAMA oncology
Published: September 18, 2025
68Ga-PSMA-11 PET/CT for Initial Staging of Unfavorable Intermediate-Risk and High-Risk Prostate Cancer Predicts Overall Survival: An IAEA Multicenter Study.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: September 05, 2025
A Multicenter Randomized Controlled Trial of Antimicrobial Prophylaxis to Prevent Urinary Tract Infections after Shockwave Lithotripsy for Urolithiasis: The APPEAL Trial.
Journal: European urology
Published: June 29, 2025
68Ga-PSMA-11 in Staging of Unfavorable Intermediate- and High-Risk Prostate Cancer Reduces Indication for Noncurative Prostatectomy: A Prospective, Multicenter, IAEA Study.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: June 20, 2025
Predicting side-specific extraprostatic extension in prostate cancer using an 18F-DCFPyL PSMA-PET/CT-based nomogram.
Journal: Prostate cancer and prostatic diseases
Published: February 05, 2025
Androgen Receptor Pathway Inhibitor Therapy for Advanced Prostate Cancer: Secondary Analysis of a Randomized Clinical Trial.
Journal: JAMA network open
Published: January 13, 2025
Improved Outcomes with Enzalutamide in Biochemically Recurrent Prostate Cancer.
Journal: The New England journal of medicine
Published: October 18, 2023
Last Updated: 09/26/2026